PrimeRFP SCOUT · Federal Contract Recompete Brief

1333ND21PNB640658OPTION PERIOD i exercise-service agreement — Bio-Rad Laboratories, Inc

Bio-Rad Laboratories, Inc holds $5.5M across 240 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Oct 27, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Department of Commerce (DOC)

Agency

Bio-Rad Laboratories, Inc

Recipient

Oct 27, 2023

PoP end

$11K

Obligated

$135K

Potential

334516

NAICS

6640

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Bio-Rad Laboratories, Inc — $90

Contract facts

NONE

Contract number1333ND21PNB640658

AgencyDepartment of Commerce (DOC)

IncumbentBio-Rad Laboratories, Inc

CAGE0UCZ8

UEISSHPDYFGN7J9

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640

Place of performanceHERCULES CA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitation1333ND21QNB640551

PoP startSep 21, 2021

PoP end (current)Oct 27, 2023

PoP end (w/ options)Jan 20, 2027

Obligated$11K

Current value$101K

Potential value$135K

OPTION PERIOD I EXERCISE-SERVICE AGREEMENT is a federal NONE award for Department of Commerce (DOC) held by Bio-Rad Laboratories, Inc. Estimated value $135K ($11K obligated). Current period of performance ends Oct 27, 2023 (potential Jan 20, 2027). Last award drew 1 bidder. Place of performance: HERCULES CA. Related solicitation 1333ND21QNB640551.

OPTION PERIOD I EXERCISE-SERVICE AGREEMENT

Recompete timing

Public

● Past PoP end (1029 days ago)

Current PoP ended Oct 27, 2023 (1029 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Bio-Rad Laboratories, Inc — $5.5M obligated across 240 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($5.5M) · all agencies · Top 4 shown (89%); remaining ~11% is other agencies.

Department of Health and Human Services (HHS)$3.1M · 56%Department of Veterans Affairs (VA)$755K · 14%Department of Agriculture (USDA)$687K · 12%Department of Commerce (DOC)$358K · 7%

Open full company profile →

Related awards

Same incumbent

140D0426P0119

(1) BIO-RAD AUTOMATIC DROPLET GENERATOR (ADG S/N# 773BR3501) AND ONE (1) QX600 DROPLET REA…

$111K

Aug 19, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 1333ND21PNB640658?

1333ND21PNB640658 (OPTION PERIOD i exercise-service agreement) is a Department of Commerce (DOC) award with a potential value of $135K, currently held by Bio-Rad Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 1333ND21PNB640658?

Department of Commerce (DOC) awarded 1333ND21PNB640658 to Bio-Rad Laboratories, Inc (potential $135K).

Who is the incumbent on 1333ND21PNB640658?

Bio-Rad Laboratories, Inc is the incumbent with $5.5M across 240 related awards in SCOUT’s public footprint. The current period of performance ends Oct 27, 2023.

When does Bio-Rad Laboratories, Inc’s 1333ND21PNB640658 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 27, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Sep 13, 2022